From CRISPR to DNA writing: expanding the gene editing toolbox

“It is amazing to witness the speed by which discovery can now be translated into practice.”

Abi Pinchbeck (Editor, BioInsights) speaks to Laura Sepp-Lorenzino (Scientific Advisor and former CSO, Intellia Therapeutics) about the evolution and future of gene editing, focusing on CRISPR-based therapies. They also discuss major scientific advancements, clinical successes, delivery challenges, and the promise of emerging technologies, such as base editing, prime editing, and DNA writing.

Please enter your email to access content Read now